β-escin selectively targets the glioblastoma-initiating cell population and reduces cell viability

Elizabeth Harford-Wright 1 Nicolas Bidère 1 Julie Gavard 1, *
* Auteur correspondant
1 Equipe 15 - SOAP - Signaling in Oncogenesis, Angiogenesis and Permeability
CHU Angers, Hôtel-Dieu de Nantes, Hôpital Laennec, CNRS - Centre National de la Recherche Scientifique : UMR6299, CRCNA - Centre de Recherche en Cancérologie/Nantes - Angers
Abstract : Glioblastoma multiforme (GBM) is a highly aggressive tumour of the central nervous system and is associated with an extremely poor prognosis. Within GBM exists a subpopulation of cells, glioblastoma-initiating cells (GIC), which possess the characteristics of progenitor cells, have the ability to initiate tumour growth and resist to current treatment strategies. We aimed at identifying novel specific inhibitors of GIC expansion through use of a large-scale chemical screen of approved small molecules. Here, we report the identification of the natural compound β-escin as a selective inhibitor of GIC viability. Indeed, β-escin was significantly cytotoxic in nine patient-derived GIC, whilst exhibiting no substantial effect on the other human cancer or control cell lines tested. In addition, β-escin was more effective at reducing GIC growth than current clinically used cytotoxic agents. We further show that β-escin triggers caspase-dependent cell death combined with a loss of stemness properties. However, blocking apoptosis could not rescue the β-escin-induced reduction in sphere formation or stemness marker activity, indicating that β-escin directly modifies the stem identity of GIC, independent of the induction of cell death. Thus, this study has repositioned β-escin as a promising potential candidate to selectively target the aggressive population of initiating cells within GBM.
Type de document :
Article dans une revue
Oncotarget, Impact journals, 2016, Epub ahead of print. 〈10.18632/oncotarget.11784〉
Liste complète des métadonnées

Littérature citée [54 références]  Voir  Masquer  Télécharger

http://www.hal.inserm.fr/inserm-01385219
Contributeur : Elizabeth Bernardo <>
Soumis le : vendredi 21 octobre 2016 - 09:23:25
Dernière modification le : jeudi 11 janvier 2018 - 06:28:10

Fichier

2016-Harford-OncotargetEqu15.p...
Fichiers éditeurs autorisés sur une archive ouverte

Identifiants

Collections

Citation

Elizabeth Harford-Wright, Nicolas Bidère, Julie Gavard. β-escin selectively targets the glioblastoma-initiating cell population and reduces cell viability. Oncotarget, Impact journals, 2016, Epub ahead of print. 〈10.18632/oncotarget.11784〉. 〈inserm-01385219〉

Partager

Métriques

Consultations de la notice

94

Téléchargements de fichiers

74